Insider Trading activities at Heartware Ltd (ASX:HTW) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heartware Ltd (ASX:HTW) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Heartware Ltd. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1389072.

Total stock buying since 2010: $8,032,611.
Total stock sales since 2010: $280,407,818.
Total stock option exercises since 2010: $6,543,423.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies

1 2 3

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Heartware Ltd* (*ASX:HTW*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2016	1,000	$32,170	7,000	$394,736	18,500	$0
2015	0	$0	318,256	$26,557,325	81,435	$30,609
2014	100,150	$7,714,361	85,663	$7,704,762	88,239	$485,580
2013	0	$0	228,561	$21,162,483	172,385	$3,453,855
2012	0	$0	618,926	$50,704,805	185,991	$1,592,629
2011	4,000	$286,080	168,870	$11,248,278	161,395	$669,544
2010	0	$0	2,097,235	$162,635,429	121,093	$311,206

Table 3. Detailed insider trading at *Heartware Ltd* (*ASX:HTW*) , Part 2
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2014-03-11	Mcaree Peter F (SVP, CFO and Treasurer)	Sale	465	93.71	43,575
2014-03-10	Hathaway David R (Chief Medical Officer)	Sale	1,601	95.00	152,095
2014-03-10	Hathaway David R (Chief Medical Officer)	Option Ex	299	18.08	5,405
2014-03-10	Schuermann James (SVP, Sales & Marketing)	Sale	2,000	94.22	188,440
2014-03-10	Schuermann James (SVP, Sales & Marketing)	Option Ex	2,000	23.79	47,580
2014-03-10	Larose Jeffrey (Chief Scientific Officer)	Sale	5,018	93.56	469,484
2014-03-06	Mcaree Peter F (SVP, CFO and Treasurer)	Option Ex	1,400	.00	0
2014-03-03	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	93.36	203,442
2014-03-03	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.61	34,014
2014-02-10	Yocher Robert E (SVP, Regulatory & Quality)	Sale	428	94.57	40,475
2014-02-10	Knopf Lawrence J (General Counsel)	Sale	714	94.61	67,551
2014-02-10	Schuermann James (SVP, Sales & Marketing)	Sale	810	94.72	76,723
2014-02-10	Larose Jeffrey (Chief Scientific Officer)	Sale	685	94.58	64,787
2014-02-10	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	2,428	94.57	229,615
2014-02-10	Mcaree Peter F (SVP, CFO and Treasurer)	Sale	714	94.62	67,558
2014-02-07	Yocher Robert E (SVP, Regulatory & Quality)	Option Ex	800	.00	0
2014-02-07	Knopf Lawrence J (General Counsel)	Option Ex	1,400	.00	0
2014-02-07	Schuermann James (SVP, Sales & Marketing)	Option Ex	1,600	.00	0
2014-02-07	Larose Jeffrey (Chief Scientific Officer)	Option Ex	1,600	.00	0
2014-02-07	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	5,000	.00	0
2014-02-07	Mcaree Peter F (SVP, CFO and Treasurer)	Option Ex	1,400	.00	0
2014-02-03	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	98.64	214,936
2014-02-03	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.31	33,360
2014-01-07	Larose Jeffrey (Chief Scientific Officer)	Sale	15,342	100.00	1,534,200
2014-01-06	Knopf Lawrence J (General Counsel)	Sale	861	97.50	83,947
2014-01-06	Harrison Seth Loring (Director)	Sale	7,909	99.29	785,284
2014-01-02	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	92.96	202,559
2014-01-02	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.62	34,035
2013-12-23	Yocher Robert E (SVP, Regulatory & Quality)	Sale	482	90.96	43,842
2013-12-23	Knopf Lawrence J (General Counsel)	Sale	723	90.99	65,785
2013-12-23	Hathaway David R (Chief Medical Officer)	Sale	602	91.03	54,800
2013-12-23	Schuermann James (SVP, Sales & Marketing)	Sale	1,204	91.36	109,997
2013-12-23	Larose Jeffrey (Chief Scientific Officer)	Sale	1,873	91.36	171,107
2013-12-23	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	4,333	91.36	395,841
2013-12-21	Yocher Robert E (SVP, Regulatory & Quality)	Option Ex	1,000	.00	0
2013-12-21	Knopf Lawrence J (General Counsel)	Option Ex	1,500	.00	0
2013-12-21	Hathaway David R (Chief Medical Officer)	Option Ex	1,250	.00	0
2013-12-21	Schuermann James (SVP, Sales & Marketing)	Option Ex	2,500	.00	0
2013-12-21	Larose Jeffrey (Chief Scientific Officer)	Option Ex	4,375	.00	0
2013-12-21	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	9,000	.00	0
2013-12-20	Hathaway David R (Chief Medical Officer)	Sale	609	91.94	55,991
2013-12-20	Hathaway David R (Chief Medical Officer)	Option Ex	1,263	.00	0
2013-12-20	Schuermann James (SVP, Sales & Marketing)	Sale	1,405	92.00	129,260
2013-12-20	Schuermann James (SVP, Sales & Marketing)	Option Ex	2,917	.00	0
2013-12-20	Larose Jeffrey (Chief Scientific Officer)	Sale	1,199	91.97	110,278
2013-12-20	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,800	.00	0
2013-12-20	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	2,703	92.05	248,797
2013-12-20	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	5,613	.00	0
2013-12-18	Thomas Robert Bain (Director)	Sale	6,942	92.27	640,538
2013-12-06	Thomas Robert Bain (Director)	Sale	3,000	95.29	285,870
2013-12-04	Thomas Robert Bain (Director)	Sale	2,500	95.54	238,850
2013-12-02	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	96.39	210,033
2013-12-02	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.94	34,733
2013-12-02	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	13,000	95.58	1,242,605
2013-12-02	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	13,000	35.06	455,780
2013-11-15	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	10,000	90.00	900,000
2013-11-15	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	10,000	35.92	359,200
2013-11-07	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	85.44	186,173
2013-11-07	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	16.65	36,280
2013-11-07	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	8,000	82.37	658,960
2013-11-07	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	3,000	36.64	109,920
2013-10-14	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	8,000	75.03	600,200
2013-10-14	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	3,000	36.44	109,320
2013-09-03	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	78.86	171,835
2013-09-03	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.70	34,210
2013-09-03	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	8,000	78.31	626,480
2013-09-03	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	3,000	34.54	103,620
2013-08-01	Schuermann James (SVP, Sales & Marketing)	Sale	1,000	93.07	93,070
2013-08-01	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	93.50	203,747
2013-08-01	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.77	34,362
2013-08-01	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	18,000	94.74	1,705,320
2013-08-01	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	13,000	34.70	451,100
2013-07-31	Larkin C Raymond Jr (Director)	Option Ex	564	.00	0
2013-07-29	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	7,530	92.64	697,541
2013-07-29	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	2,530	35.63	90,143
2013-07-26	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	12,834	93.29	1,197,283
2013-07-26	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	12,834	35.32	453,296
2013-07-25	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	12,636	93.63	1,183,108
2013-07-25	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	12,636	35.53	448,957
2013-07-10	Mcaree Peter F (SVP, CFO and Treasurer)	Sale	2,950	93.58	276,061
2013-07-09	Mcaree Peter F (SVP, CFO and Treasurer)	Option Ex	6,250	.00	0
2013-07-01	Harrison Seth Loring (Director)	Sale	13,118	95.60	1,254,080
2013-07-01	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	95.92	209,009
2013-07-01	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	15.98	34,820
2013-06-26	Knopf Lawrence J (General Counsel)	Sale	992	95.00	94,240
2013-06-25	Yocher Robert E (SVP, Regulatory & Quality)	Sale	1,162	94.25	109,518
2013-06-23	Yocher Robert E (SVP, Regulatory & Quality)	Option Ex	2,500	.00	0
2013-06-17	Larose Jeffrey (Chief Scientific Officer)	Sale	2,179	91.14	198,594
2013-06-17	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,179	16.74	36,476
2013-06-06	Thomas Robert Bain (Director)	Sale	2,656	90.41	240,128
2013-05-30	Thomas Robert Bain (Director)	Sale	57	94.05	5,360
2013-05-29	Thomas Robert Bain (Director)	Sale	714	93.50	66,762
2013-05-28	Hathaway David R (Chief Medical Officer)	Sale	5,934	95.05	564,026
2013-05-28	Hathaway David R (Chief Medical Officer)	Option Ex	4,491	19.22	86,317
2013-05-28	Thomas Robert Bain (Director)	Sale	2,786	93.02	259,145
2013-05-23	Thomas Robert Bain (Director)	Sale	2,300	91.90	211,370
2013-05-22	Hathaway David R (Chief Medical Officer)	Sale	2,400	95.15	228,360
2013-05-22	Hathaway David R (Chief Medical Officer)	Option Ex	2,400	19.55	46,920
2013-05-21	Hathaway David R (Chief Medical Officer)	Sale	17,140	96.31	1,650,753
2013-05-21	Hathaway David R (Chief Medical Officer)	Option Ex	17,140	19.51	334,401
2013-05-21	Thomas Robert Bain (Director)	Sale	200	97.69	19,538
2013-05-20	Knopf Lawrence J (General Counsel)	Sale	2,000	97.72	195,440
2013-05-20	Hathaway David R (Chief Medical Officer)	Sale	10,000	97.89	978,900
2013-05-20	Hathaway David R (Chief Medical Officer)	Option Ex	10,000	19.40	194,000
2013-05-20	Wade Denis Newell (Director)	Sale	4,000	99.00	396,000
2013-05-20	Thomas Robert Bain (Director)	Sale	6,429	98.08	630,582
2013-05-20	Larose Jeffrey (Chief Scientific Officer)	Sale	9,574	97.94	937,629
2013-05-12	Harrison Seth Loring (Director)	Option Ex	250	.00	0
2013-05-12	Wade Denis Newell (Director)	Option Ex	250	.00	0
2013-05-12	Stockman Robert Bernard (Director)	Option Ex	250	.00	0
2013-05-12	Thomas Robert Bain (Director)	Option Ex	250	.00	0
2013-05-12	Barberich Timothy J (Director)	Option Ex	250	.00	0
2013-05-12	Larkin C Raymond Jr (Director)	Option Ex	250	.00	0
2013-05-04	Harrison Seth Loring (Director)	Option Ex	333	.00	0
2013-05-04	Wade Denis Newell (Director)	Option Ex	333	.00	0
2013-05-04	Stockman Robert Bernard (Director)	Option Ex	333	.00	0
2013-05-04	Thomas Robert Bain (Director)	Option Ex	333	.00	0
2013-05-04	Barberich Timothy J (Director)	Option Ex	333	.00	0
2013-05-04	Larkin C Raymond Jr (Director)	Option Ex	333	.00	0
2013-05-01	Schuermann James (SVP, Sales & Marketing)	Sale	1,000	97.20	97,200
2013-05-01	Harrison Seth Loring (Director)	Option Ex	250	.00	0
2013-05-01	Wade Denis Newell (Director)	Option Ex	250	.00	0
2013-05-01	Stockman Robert Bernard (Director)	Option Ex	250	.00	0
2013-05-01	Thomas Robert Bain (Director)	Option Ex	250	.00	0
2013-05-01	Feldmann Cynthia L (Director)	Option Ex	500	.00	0
2013-05-01	Barberich Timothy J (Director)	Option Ex	250	.00	0
2013-05-01	Larkin C Raymond Jr (Director)	Option Ex	250	.00	0
2013-03-28	Knopf Lawrence J (General Counsel)	Sale	2,500	88.75	221,887
2013-03-28	Knopf Lawrence J (General Counsel)	Option Ex	5,250	.00	0
2013-02-01	Schuermann James (SVP, Sales & Marketing)	Sale	1,000	90.59	90,590
2012-12-21	Yocher Robert E (SVP, Regulatory & Quality)	Sale	426	81.97	34,921
2012-12-21	Yocher Robert E (SVP, Regulatory & Quality)	Option Ex	1,000	.00	0
2012-12-21	Knopf Lawrence J (General Counsel)	Sale	639	81.97	52,382
2012-12-21	Knopf Lawrence J (General Counsel)	Option Ex	1,500	.00	0
2012-12-21	Hathaway David R (Chief Medical Officer)	Sale	532	81.97	43,610
2012-12-21	Hathaway David R (Chief Medical Officer)	Option Ex	1,250	.00	0
2012-12-21	Schuermann James (SVP, Sales & Marketing)	Sale	1,064	81.98	87,226
2012-12-21	Schuermann James (SVP, Sales & Marketing)	Option Ex	2,500	.00	0
2012-12-21	Larose Jeffrey (Chief Scientific Officer)	Sale	1,627	81.98	133,381
2012-12-21	Larose Jeffrey (Chief Scientific Officer)	Option Ex	4,375	.00	0
2012-12-21	Godshall Douglas Evan (President & Chief Exec Officer)	Sale	3,829	81.97	313,882
2012-12-21	Godshall Douglas Evan (President & Chief Exec Officer)	Option Ex	9,000	.00	0
2012-12-21	Farrell Lauren (VP, Finance)	Sale	405	81.97	33,197
2012-12-21	Farrell Lauren (VP, Finance)	Option Ex	1,250	.00	0
2012-12-20	Hathaway David R (Chief Medical Officer)	Sale	537	82.09	44,082
2012-12-20	Hathaway David R (Chief Medical Officer)	Option Ex	1,262	.00	0
2012-12-20	Schuermann James (SVP, Sales & Marketing)	Sale	532	82.09	43,671
2012-12-20	Schuermann James (SVP, Sales & Marketing)	Option Ex	1,250	.00	0
2012-12-20	Larose Jeffrey (Chief Scientific Officer)	Sale	1,042	82.09	85,537
2012-12-20	Larose Jeffrey (Chief Scientific Officer)	Option Ex	2,800	.00	0

1 2 3

Insider trading activities including stock purchases, stock sales, and option exercises of ASX:HTW listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Heartware Ltd (symbol ASX:HTW, CIK number 1389072) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month